Detection of early relapse in multiple myeloma patients
Mass spectrometry coupled with machine learning shows potential as a reliable, rapid, and cost-effective preliminary screening technique to supplement current diagnostics.
Authors
- Josef Havel (ORCID: https://orcid.org/0000-0002-6675-5671)
- Lukáš Pečínka (ORCID: https://orcid.org/0000-0002-5763-5942)
- Luděk Pour (ORCID: https://orcid.org/0000-0002-6274-7009)
- Sabina Ševčı́ková (ORCID: https://orcid.org/0000-0002-7194-6771)
- Marie Jarošová (ORCID: https://orcid.org/0000-0002-2194-3433)
- Lenka Radová (ORCID: https://orcid.org/0000-0001-8103-148X)
- Monika Brychtová
- Monika Vlachová
- Marek Večeřa (ORCID: https://orcid.org/0000-0001-7510-3694)
- Tereza Růžičková
Institutions
- Central European Institute of Technology (CZ)
- Masaryk University (CZ)
- Central European Institute of Technology – Masaryk University (CZ)
- University Hospital Brno (CZ)
- Masaryk Memorial Cancer Institute (CZ)
- St. Anne's University Hospital Brno (CZ)
Publication Details
- Journal
- Cell Division
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1186/s13008-025-00143-3
- Citations
- 5
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.85
Funders
- European Commission
- Ministerstvo Zdravotnictví Ceské Republiky
- Masarykova Univerzita